An observational study in Arthritis, Rheumatoid and Distress, Emotional, sponsored by Bozyaka Training and Research Hospital. Recruiting at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-10-05.
Sponsored by Bozyaka Training and Research Hospital · Observational
Among 126 studies in Arthritis, Rheumatoid with a site in Turkey — 14 open to participants now, 19 under way, 2 of them phase 3. Arthritis, Rheumatoid · Turkey.
Among the 126 studies in Arthritis, Rheumatoid with a site in Turkey, this one is the 29th largest by planned enrollment of the 49 observational ones, is one of 18 that started in 2023, is one of 49 observational ones, reaches primary completion later than 2 of the 18 other live ones, and was the 83rd registered.
3,332 studies on the registry are indexed under Arthritis, Rheumatoid; 443 are open to participants now.
This study's planned enrollment of 90 is below the median of 176 across 1,016 observational studies indexed under Arthritis, Rheumatoid.
Browse Arthritis, Rheumatoid studies →14 of the 126 studies in Arthritis, Rheumatoid with a site in Turkey are open now, in 1 country. Each count lists the studies.
Of the 293 Arthritis, Rheumatoid studies recruiting now, 150 (51%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →126 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 18 started in 2023.
Median enrollment 80 across the 77 interventional studies, 100 across the 49 observational. Of the 97 that completed or were terminated, 31 (32%) have results posted.
38 of 126 have an industry lead sponsor. The 10 most frequent:
Bozyaka Training and Research Hospital is the lead sponsor of 51 studies on the registry; 5 are open to participants now.
Bozyaka Training and Research Hospital has 2 studies filed under Arthritis, Rheumatoid — fewer than ten, so there is no comparison to draw.
3 of the studies in Arthritis, Rheumatoid with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07627542Merve ŞahinAn Investigation of the Effect of Smartphone Usage Levels on Cervical Posture, Tongue Pressure, Balance, and Neck Disability in Individuals With Rheumatoid Arthritis and Ankylosing Spondylitis | 2026-11 |
| NCT07666594Tugba Civi KaraaslanMobile App-Based Yoga and Meditation in Rheumatoid Arthritis | 2027-05 |
| NCT07274124Medipol UniversityPain Neuroscience Education and Vagus Nerve Stimulation on Recovery in Individuals With Rheumatoid Arthritis | 2027-05 |
Among the 126 studies in Arthritis, Rheumatoid with a site in Turkey, from their registry updates:
The goal of this observational study is to determine the frequency of psychological distress caused by the rheumatoid arthritis disease in patients with rheumatoid arthritis and to determine the factors associated with the distress.
A routine rheumatoid arthritis patient examination (number of swollen and tender joints, disease activity, functional status, etc.) will be performed by the doctor to evaluate the patients. Patients will be asked to fill out the questionnaires to evaluate their functional status and distress levels.
Demographic data such as age, gender, body mass index and disease duration will be recorded during routine follow-up of the patients. The duration of morning stiffness, the number of swollen and tender joints, disease activity and functional status will be evaluated by the doctor. Disease activity will be evaluated with the DAS 28 score and functional status will be evaluated with the Health Assessment Questionnaire. Rheumatoid Arthritis Distress Scale (RADS) will be used to evaluate the distress due to rheumatoid arthritis.Patients will be asked to fill out the questionnaires to evaluate their functional status and distress levels.
Demographic data such as age, gender, body mass index and disease duration will be recorded during routine follow-up of the patients. The duration of morning stiffness, the number of swollen and tender joints, disease activity and functional status will be evaluated by the doctor. Disease activity will be evaluated with the DAS 28 score and functional status will be evaluated with the Health Assessment Questionnaire. Rheumatoid Arthritis Distress Scale (RADS) will be used to evaluate the distress due to rheumatoid arthritis.
DAS28 score is a score calculated by a mathematical formula based on the patient's swollen and tender joint counts, erythrocyte sedimentation rate and the patient's global assessment of disease activity.
The Health Assessment Questionnaire consists of twenty items and evaluates the degree of difficulty patients have in performing daily living activities. The total score varies between 0 and 3, with a higher score indicating a more serious impact on daily functional status.
Rheumatoid Arthritis Distress Scale (RADS) is a scale developed to evaluate the psychological distress experienced in patients with rheumatoid arthritis due to the effects of the disease. The total score varies between 0 and 5, with a higher score indicating more impact.
Patients aged 18 years and older, diagnosed with rheumatoid arthritis.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
To evaluate the effects of psychological distress caused by living with a chronic disease such as rheumatoid arthritis.
Distress
Presence of distress related with rheumatoid arthritis will be evaluated by Rheumatoid Arthritis Distress Scale.
Time frame: 10 months
Disease activity
Disease activity will be evaluated by DAS 28 score.
Time frame: 10 months
Functional status
Functional status of patients will be evaluated by HAQ.
Time frame: 10 months
Plan to share: No
Started Jan 2023 (actual). Primary completion is estimated for Nov 2023, 10 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bozyaka Training and Research Hospital